Arnold M. Kloos

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients.

Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients.

Journal: Blood advances

Published: February 02, 2026

Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Journal: Science translational medicine

Published: November 26, 2025

Base edited "universal" donor CAR T-cell strategies for acute myeloid leukaemia.

Base edited "universal" donor CAR T-cell strategies for acute myeloid leukaemia.

Journal: Leukemia

Published: January 11, 2025

XPO1-dependency of DEK::NUP214 leukemia.

XPO1-dependency of DEK::NUP214 leukemia.

Journal: Leukemia

Published: July 12, 2024

Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia.

Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia.

Journal: Journal for immunotherapy of cancer

Published: December 04, 2023

A 19-color single-tube full spectrum flow cytometry assay for the detection of measurable residual disease in acute myeloid leukemia.

A 19-color single-tube full spectrum flow cytometry assay for the detection of measurable residual disease in acute myeloid leukemia.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology

Published: July 10, 2023

Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients.

Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients.

Journal: HemaSphere

Published: March 30, 2023

Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.

Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.

Journal: Haematologica

Published: February 08, 2023

Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia.

Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia.

Journal: Leukemia

Published: November 03, 2021

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123.

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123.

Journal: Viruses

Published: June 04, 2021

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.

Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.

Journal: Blood advances

Published: January 25, 2021

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia.

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia.

Journal: Cancers

Published: July 23, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026